Cargando…

Determining the role of novel metabolic pathways in driving intracranial pressure reduction after weight loss

Idiopathic intracranial hypertension, a disease classically occurring in women with obesity, is characterized by raised intracranial pressure. Weight loss leads to the reduction in intracranial pressure. Additionally, pharmacological glucagon-like peptide-1 agonism reduces cerebrospinal fluid secret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alimajstorovic, Zerin, Mitchell, James L, Yiangou, Andreas, Hancox, Thomas, Southam, Andrew D, Grech, Olivia, Ottridge, Ryan, Winder, Catherine L, Tahrani, Abd A, Tan, Tricia M, Mollan, Susan P, Dunn, Warwick B, Sinclair, Alexandra J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608960/ https://www.ncbi.nlm.nih.gov/pubmed/37901040 http://dx.doi.org/10.1093/braincomms/fcad272

Ejemplares similares

The Health Economic Evaluation of Bariatric Surgery Versus a Community Weight Management Intervention Analysis from the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT)
por: Aguiar, Magda, et al.
Publicado: (2021)

Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
por: Grech, Olivia, et al.
Publicado: (2021)

Cost-effectiveness of bariatric surgery versus community weight management to treat obesity-related idiopathic intracranial hypertension: evidence from a single-payer healthcare system
por: Elliot, Laura, et al.
Publicado: (2021)

Association of Amount of Weight Lost After Bariatric Surgery With Intracranial Pressure in Women With Idiopathic Intracranial Hypertension
por: Mollan, Susan P., et al.
Publicado: (2022)

Dysregulation of Amino Acid, Lipid, and Acylpyruvate Metabolism in Idiopathic Intracranial Hypertension: A Non-targeted Case Control and Longitudinal Metabolomic Study
por: Alimajstorovic, Zerin, et al.
Publicado: (2022)

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)

Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
por: Mollan, S. P., et al.
Publicado: (2021)

Emerging themes in idiopathic intracranial hypertension
por: Grech, Olivia, et al.
Publicado: (2020)

Nuclear Magnetic Resonance Spectroscopy Metabolomics in Idiopathic Intracranial Hypertension to Identify Markers of Disease and Headache
por: Grech, Olivia, et al.
Publicado: (2022)

Evaluation of diurnal and postural intracranial pressure employing telemetric monitoring in idiopathic intracranial hypertension
por: Mitchell, James L, et al.
Publicado: (2022)

The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
por: Mitchell, James L, et al.
Publicado: (2023)

Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial
por: Mollan, Susan P., et al.
Publicado: (2021)

Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension
por: Westgate, Connar S.J., et al.
Publicado: (2021)

Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)
por: Yiangou, Andreas, et al.
Publicado: (2021)

Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain?
por: Yiangou, Andreas, et al.
Publicado: (2018)

11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension
por: Hardy, Rowan S, et al.
Publicado: (2020)

Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension
por: Yiangou, Andreas, et al.
Publicado: (2020)

11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial
por: Markey, Keira, et al.
Publicado: (2020)

Managing idiopathic intracranial hypertension in pregnancy: practical advice
por: Thaller, Mark, et al.
Publicado: (2022)

Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol
por: Ottridge, Ryan, et al.
Publicado: (2017)

Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema
por: Mollan, Susan P., et al.
Publicado: (2021)

A Neuro-Ophthalmologist’s Guide to Advances in Intracranial Pressure Measurements
por: Mollan, Susan P, et al.
Publicado: (2023)

Weight Management Interventions for Adults With Idiopathic Intracranial Hypertension: A Systematic Review and Practice Recommendations
por: Abbott, Sally, et al.
Publicado: (2023)

Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom
por: Adderley, Nicola J., et al.
Publicado: (2019)

Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
por: Westgate, Connar S J, et al.
Publicado: (2022)

Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension
por: Aojula, Anuriti, et al.
Publicado: (2018)

Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension
por: Mitchell, James L., et al.
Publicado: (2019)

Evaluation and management of adult idiopathic intracranial hypertension
por: Mollan, Susan P, et al.
Publicado: (2018)

Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online survey
por: Scotton, William J, et al.
Publicado: (2018)

The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes
por: Thaller, Mark, et al.
Publicado: (2022)

Advances in the understanding of headache in idiopathic intracranial hypertension
por: Mollan, Susan P., et al.
Publicado: (2019)

Multiple lumbar punctures aiming to relieve headache results in iatrogenic spinal hematoma: a case report
por: Lyons, Hannah S., et al.
Publicado: (2022)

Visual Field Pointwise Analysis of the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT)
por: Mollan, Susan P., et al.
Publicado: (2023)

The expanding burden of idiopathic intracranial hypertension
por: Mollan, Susan P., et al.
Publicado: (2018)

Topiramate is more effective than acetazolamide at lowering intracranial pressure
por: Scotton, William J, et al.
Publicado: (2018)

Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension
por: Thaller, M., et al.
Publicado: (2021)

Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial
por: Markey, Keira Annie, et al.
Publicado: (2017)

Headache determines quality of life in idiopathic intracranial hypertension
por: Mulla, Yasmeen, et al.
Publicado: (2015)

Alterations in metabolic flux in migraine and the translational relevance
por: Grech, Olivia, et al.
Publicado: (2022)

Reviewing the Recent Developments in Idiopathic Intracranial Hypertension
por: Virdee, Jasvir, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fqqt3qru3mugmp3atb4kkhr89p